Lonza develops its capacity for virale products
The building of a new cGMP Reinraums will extend large-scale projects in the range of the viralen vaccines as well as the gene therapy unterst�tzenLonza will their virus-based Therapeutik business by the building of a new, ultramodern cGMP Reinraums in their plants in Houston, already existing, Te…








